No black box warning on record for Glycopyrrolate

As of the latest FDA labeling reviewed, Glycopyrrolate (GLYCOPYRROLATE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Glycopyrrolate medicine page for the complete safety profile.

Other warnings & precautions

WARNINGS This drug should be used with great caution, if at all, in patients with glaucoma. Exposure to excessive amounts of benzyl alcohol has been associated with toxicity (hypotension, metabolic acidosis), particularly in neonates, and an increased incidence of kernicterus, particularly in small preterm infants. There have been rare reports of deaths, primarily in preterm infants, associated wi

No black box warning on record for Glycopyrrolate

Other warnings & precautions

WARNINGS This drug should be used with great caution, if at all, in patients with glaucoma. Exposure to excessive amounts of benzyl alcohol has been associated with toxicity (hypotension, metabolic acidosis), particularly in neonates, and an increased incidence of kernicterus, particularly in small preterm infants. There have been rare reports of deaths, primarily in preterm infants, associated wi

Glycopyrrolate Black Box Warning

No black box warning on record for Glycopyrrolate

Other warnings & precautions

Glycopyrrolate Black Box Warning

No black box warning on record for Glycopyrrolate

Other warnings & precautions